Product Images Afluria
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Afluria NDC 33332-024 by Seqirus Pty Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Principal Display Panel – 5 mL Carton Label - afl0h 0014 01
This is the information of an influenza vaccine named afluria for the 2024-2025 formula. The vaccine is made from virus grown in embryonated chicken eggs and inactivated with beta-propiolactone. It contains the preservative thimerosal, with 24.5 mcg mercury per 0.5 mL dose and 12.25 mcg mercury per 0.25 mL dose. The vaccine does not contain natural rubber latex. It has trace amounts of polymysin, neomycin, and hydrocortisone from the early stages of manufacture.*
Principal Display Panel – 5 mL Vial Label - afl0h 0014 02
This text appears to be a description of a vaccine. It provides instructions for use, dosage information based on age, storage conditions, and manufacturing and distribution details. The vaccine is for intramuscular use only and specifies different doses for different age groups. It also mentions not to freeze the vaccine and to shake well before use. The manufacturer is Seqirus Pty Ltd located in Australia, while the distribution is handled by Seqirus USA Inc. located in the USA.*
Principal Display Panel – 0.5 mL Carton Label - afl0h 0014 03
This text provides detailed information about the influenza vaccine Afluria® for the 2024-2025 season. It includes the specific strains of influenza virus contained in the vaccine, dosage information, storage instructions, manufacturing process, and contact details for the manufacturer. The vaccine is prepared from virus grown in chicken eggs and inactivated with beta-propiolactone. It does not contain preservatives or natural rubber latex. The packaging includes 10 pre-filled syringes, each with a 0.5 mL dose, and is intended for intramuscular use in individuals aged 3 years and older. It is essential to store the vaccine between 2 - 8°C and protect it from light.*
Principal Display Panel – 0.5 mL Vial Label - afl0h 0014 04
This text appears to be a label or information from a medical product. It mentions a 0.5 mL dosage of something called "Ronly" intended for use in children aged 3 years and older. The product is manufactured by Seqirus Pty Ltd in Parkville, Australia. It includes a US license number and a lot number "Bp." Contact information is also provided with a phone number.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
